Jupiter Neurosciences Inc (JUNS)

$1.03 -0.02 (-1.44%)
Market Cap 35.98M
Revenue (ttm) 0.00
Net Income (ttm) -2.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 17.58
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 67,900
Avg Vol 86,974
Day's Range N/A - N/A
Shares Out 34.43M
Stochastic %K 40%
Beta N/A
Analysts Sell
Price Target $25.00

Company Profile

Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform products for the treatment of neuroinflammation. The company develops JNS101, which is in Phase II trial for the treatment of Friedreich's Ataxia, a rare inherited disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS108 that is in Phase II trial for treating mild cognitive impairment/early Alzheimer's disease. It is also involved in t...

Industry: Biotechnology
Sector: Healthcare
Phone: 561 406 6154
Address:
1001 North US Highway 1, Suite 504, Jupiter, United States
Thebullrun
Thebullrun Dec. 30 at 2:25 PM
$JUNS
0 · Reply
Thebullrun
Thebullrun Dec. 30 at 2:25 PM
$JUNS
0 · Reply
Thebullrun
Thebullrun Dec. 30 at 2:24 PM
$JUNS
0 · Reply
Thebullrun
Thebullrun Dec. 30 at 2:24 PM
$JUNS
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 30 at 1:03 PM
$JUNS
0 · Reply
Thebullrun
Thebullrun Dec. 22 at 10:56 PM
$JUNS 2026 will be a “HUGE” year for Biotech and Healthcare!! Happy holidays to all. !!
0 · Reply
JohnTrack
JohnTrack Dec. 22 at 9:39 PM
$JUNS small blurb hit seconds ago... https://www.rapidticker.com/news/juns-sec-filing-3d2ab1
0 · Reply
Thebullrun
Thebullrun Dec. 22 at 8:47 PM
$JUNS nice short squeeze!! Unlock a $50 billion opportunity in the longevity sector! Join #JupiterNeurosciences #JUNS CEO Christer Rosen and President Alison Silva for a live event at Nasdaq. Discover innovative advancements in health and wellness and learn how you can be part of this transformative journey! https://ipo-edge.com/50b-longevity-opportunity-jupiter-neurosciences-ceo-christer-rosen-president-alison-silva-live-at-nasdaq/ #VISM #DBMM #OTLC #JUNS #STOCKSTOBUY #STOCKSTOWATCH #TheBullRunShow #STOCKS FLASH NEWS Charles DAvanzo Chris Colasuonno
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 7:32 PM
$JUNS Jupiter Neurosciences: Advancing - ALERTS, HOT STOCKS & CHARTS https://investorshangout.com/post/view?id=6807653
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 5:33 PM
$JUNS Jupiter Neurosciences: Advancing World-Class Neuro Therapies with $50B+ Market Potential https://www.youtube.com/watch?v=ohMasK_hxjw
0 · Reply
Latest News on JUNS
Join Jupiter Neurosciences' Exclusive Live Investor Webinar and Q&A Session on January 6

Dec 23, 2025, 8:00 AM EST - 17 days ago

Join Jupiter Neurosciences' Exclusive Live Investor Webinar and Q&A Session on January 6

Jupiter Neurosciences to Participate in NobleCon21

Dec 2, 2025, 4:15 PM EST - 5 weeks ago

Jupiter Neurosciences to Participate in NobleCon21

Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing

Oct 27, 2025, 8:30 AM EDT - 2 months ago

Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing

Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador

Aug 19, 2025, 8:12 AM EDT - 5 months ago

Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador

Jupiter Neurosciences Highlights Critical Advancement of JOTROL™ Over Traditional Resveratrol with Breakthrough Bioavailability and CNS-Targeted Science

Jul 23, 2025, 8:00 AM EDT - 6 months ago

Jupiter Neurosciences Highlights Critical Advancement of JOTROL™ Over Traditional Resveratrol with Breakthrough Bioavailability and CNS-Targeted Science

Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jul 10, 2025, 4:05 PM EDT - 6 months ago

Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jupiter Neurosciences Showcases Nugevia™ PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery

Jun 30, 2025, 3:15 PM EDT - 6 months ago

Jupiter Neurosciences Showcases Nugevia™ PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery

Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia™ Brand Ambassador

Jun 23, 2025, 8:00 AM EDT - 7 months ago

Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia™ Brand Ambassador

Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones

Feb 4, 2025, 9:25 AM EST - 1 year ago

Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones

Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson's Trial

Jan 30, 2025, 8:00 AM EST - 1 year ago

Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson's Trial

Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering

Dec 4, 2024, 4:56 PM EST - 1 year ago

Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering

Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq

Dec 2, 2024, 7:00 PM EST - 1 year ago

Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq

Neuro-inflammation biotech Jupiter Neurosciences revises terms, removes warrants ahead of $15 million IPO

Aug 16, 2022, 5:48 PM EDT - 3 years ago

Neuro-inflammation biotech Jupiter Neurosciences revises terms, removes warrants ahead of $15 million IPO

Thebullrun
Thebullrun Dec. 30 at 2:25 PM
$JUNS
0 · Reply
Thebullrun
Thebullrun Dec. 30 at 2:25 PM
$JUNS
0 · Reply
Thebullrun
Thebullrun Dec. 30 at 2:24 PM
$JUNS
0 · Reply
Thebullrun
Thebullrun Dec. 30 at 2:24 PM
$JUNS
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 30 at 1:03 PM
$JUNS
0 · Reply
Thebullrun
Thebullrun Dec. 22 at 10:56 PM
$JUNS 2026 will be a “HUGE” year for Biotech and Healthcare!! Happy holidays to all. !!
0 · Reply
JohnTrack
JohnTrack Dec. 22 at 9:39 PM
$JUNS small blurb hit seconds ago... https://www.rapidticker.com/news/juns-sec-filing-3d2ab1
0 · Reply
Thebullrun
Thebullrun Dec. 22 at 8:47 PM
$JUNS nice short squeeze!! Unlock a $50 billion opportunity in the longevity sector! Join #JupiterNeurosciences #JUNS CEO Christer Rosen and President Alison Silva for a live event at Nasdaq. Discover innovative advancements in health and wellness and learn how you can be part of this transformative journey! https://ipo-edge.com/50b-longevity-opportunity-jupiter-neurosciences-ceo-christer-rosen-president-alison-silva-live-at-nasdaq/ #VISM #DBMM #OTLC #JUNS #STOCKSTOBUY #STOCKSTOWATCH #TheBullRunShow #STOCKS FLASH NEWS Charles DAvanzo Chris Colasuonno
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 7:32 PM
$JUNS Jupiter Neurosciences: Advancing - ALERTS, HOT STOCKS & CHARTS https://investorshangout.com/post/view?id=6807653
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 5:33 PM
$JUNS Jupiter Neurosciences: Advancing World-Class Neuro Therapies with $50B+ Market Potential https://www.youtube.com/watch?v=ohMasK_hxjw
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 4:33 PM
Jupiter Neurosciences Inc ( $JUNS ): $JUNS Jupiter Neurosciences: Advancing W... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177079513 via @Investors_Hub
0 · Reply
Thebullrun
Thebullrun Dec. 18 at 3:53 PM
$JUNS
1 · Reply
Thebullrun
Thebullrun Dec. 18 at 3:53 PM
$JUNS
0 · Reply
Thebullrun
Thebullrun Dec. 18 at 3:52 PM
$JUNS
0 · Reply
Thebullrun
Thebullrun Dec. 18 at 3:52 PM
$JUNS
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 18 at 2:12 PM
$JUNS Jupiter Neurosciences: Advancing World-Class Neuro Therapies with $50B+ Market Potential https://www.youtube.com/watch?v=ohMasK_hxjw #JUNS #STOCKSTOBUY #STOCKSTOWATCH #TEAMHIGHALERT #STOCKS
0 · Reply
Ichigodoran
Ichigodoran Dec. 17 at 7:05 PM
$JUNS Jupiter Neurosciences: Innovative Resveratrol Platform Tackles Neuroinflammation & Rare CNS Diseases https://youtu.be/zCrH6UNZIJ0?si=gDDVzqbMd9X9IDwq
0 · Reply
Ichigodoran
Ichigodoran Dec. 17 at 5:06 PM
$JUNS Investors Deck positioned to execute several steps in 2025 and 2026 Vist here - https://jupiterneurosciences.com/pdf/JUNS%20Corporate%20Presentation%202025.pdf
0 · Reply
Ichigodoran
Ichigodoran Dec. 17 at 3:27 PM
$JUNS Big News! Jupiter Neurosciences Marks Transformational First Year as a Public Company, Entering 2026 with Powerful Clinical and Commercial Momentum https://finance.yahoo.com/news/jupiter-neurosciences-marks-transformational-first-130000175.html
0 · Reply
Ichigodoran
Ichigodoran Dec. 17 at 1:49 PM
$JUNS $50B+ Longevity Opportunity: Jupiter Neurosciences CEO Christer Rosen & President Alison Silva, Live at Nasdaq https://finance.yahoo.com/news/50b-longevity-opportunity-jupiter-neurosciences-192916920.html
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 16 at 6:39 PM
$50B+ Longevity Opportunity: $JUNS - Stock On High Alert https://investorshangout.com/post/view?id=6807220
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 16 at 3:14 PM
Jupiter Neurosciences Inc ( $JUNS ): $50B+ Longevity Opportunity: $JUNS Jupit... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177070397 via @Investors_Hub
0 · Reply